Abstract
The Quality Management System (QMS) initiative of TransCelerate BioPharma Inc has identified potential benefits that could be captured from the development of a flexible, proactive clinical QMS conceptual framework for clinical research. Such a framework would aid organizations in seamlessly managing the complex clinical trial environment and, ultimately, in expediting delivery of needed treatments to patients. This article chronicles the evolution of a TransCelerate concept paper describing a proposed clinical QMS framework and reviews feedback from varied global clinical trial stakeholders during socialization of the concept paper. Many stakeholders recognized the potential for the concept paper to inform development of a harmonized International Council for Harmonisation (ICH) guideline, providing needed clarity from regulators on their expectations for QMS in the clinical realm. Accordingly, the article also describes TransCelerate’s efforts to work with regulators to facilitate harmonization on this important topic and reviews ongoing work to develop additional tools and resources that may support organizations in evaluating whether and how they might translate the conceptual framework principles into practice.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Meeker-O’Connell A, Borda MM, Little JA, Sam LM. Enhancing quality and efficiency in clinical development through a clinical QMS conceptual framework: concept paper vision and outline. Therapeutic Innovation & Regulatory Science. 2015;49:615–622.
International Conference on Harmonisation (ICH). ICH Harmonised Tripartite Guideline: Pharmaceutical Quality System Q10 (Current Step 4 version). June 4, 2008.
International Organization for Standardization. ISO 9001:2008, Quality Management Systems. November 15, 2008.
International Organization for Standardization. ISO 9001:2015, Quality Management Systems. September 15, 2015.
Clinical Trials Transformation Initiative (CTTI). QbD (Quality by Design) Toolkit. Available at http://www.ctti-clinicaltrials.org/qbd. Accessed February 23, 2016.
United States Food and Drug Administration. Guidance for industry: oversight of clinical investigations: a risk-based approach to monitoring. August 2013.
TransCelerate BioPharma. Risk based monitoring resources. http://www.transceleratebiopharmainc.com/assets/risk-based-monitoring/. Accessed April 14, 2016.
International Conference on Harmonisation (ICH). ICH Harmonised Guideline: integrated addendum to ICH E6(R1): guideline for Good Clinical Practice E6(R2) (Current Step 2 version). June 11, 2015.
Harvard Business Review Change Management page. Harvard Business Review. https://hbr.org/topic/change-management. Accessed February 23, 2016.
International Organization for Standardization. ISO 31000:2009, Risk management—principles and guidelines. November 15, 2009.
International Organization for Standardization. ISO 31010:2009, Risk management—risk assessment techniques. November 1, 2009.
O’Dell C, Hubert C. The New Edge in Knowledge: How Knowledge Management Is Changing the Way We Do Business. Hoboken, NJ: John Wiley & Sons; 2011.
Author information
Authors and Affiliations
Corresponding author
Additional information
Author Note
The organization’s mission is to collaborate across the global biopharmaceutical R&D community to identify, prioritize, design, and facilitate implementation of solutions designed to drive the efficient, effective, and high-quality delivery of new medicines.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Meeker-O’Connell, A., Sam, L.M., Bergamo, N. et al. TransCelerate’s Clinical Quality Management System: From a Vision to a Conceptual Framework. Ther Innov Regul Sci 50, 397–413 (2016). https://doi.org/10.1177/2168479016651300
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479016651300